Guidelines Call for More Transparency on Hepatitis C Drug Costs

Updated guidelines from the American Association for the Study of Liver Diseases, the Infectious Diseases Society of America and the International Antiviral Society -USA attempt to provide an overview of hepatitis C virus treatments, including cost comparisons. Learn more here, login required. (Source: Medscape, 8/26/15)

You might also be interested in:

Survey: Price Transparency Falling Short June 4, 2018
New Non-Profit Association Launches Free Guideline… January 16, 2019
Report: Doctors’ Salaries, Drug Prices Main Driver of… March 15, 2018
Epidemiologic Reviews Issues Call for Papers April 19, 2018
Levinson: Robust, Long-Term Transparency in Health Care… November 20, 2018
Study Finds Success in Value-Based Oncology Model Dependent… October 28, 2018
Pharma Mostly Posts Lower Prices in Q4 of 2017 April 5, 2018